Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Use a straightforward framework to decide between 3-6 or 12 months of expenses. Includes factors like income stability and debt levels.
18,776 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
The space-tech IPO has hit a snag, with shares slipping below the initial price. This guide breaks down what the drop...
Oil prices rise as President Trump signals a toll on Strait of Hormuz shipping, amplifying supply concerns and forcin...
Aurora Innovation saw a dramatic rally in the first half of 2026. This article explores the factors behind the move, ...
In his first congressional testimony, chief Warsh pledged to clamp down on inflation with a data-driven approach and ...
The CLARITY Act moves toward a Senate floor vote, potentially codifying XRP’s regulatory status. This piece breaks do...
Oracle just fresh 52-week lows as a credit downgrade highlights the tension between expensive AI infrastructure and c...
As Angiodynamics (ANGO) gears up for the 2026 earnings season, investors should focus on orders, backlog, margins, an...
A sweeping wave of public and private spending is reshaping where people live and work. This is the largest infrastru...
Garmin stock soared this week after the GPS giant posted a solid Q4 and guided higher for 2026. This article breaks d...
Robert Kiyosaki says he bought more BTC, doubling down on a view that bitcoin could eventually outperform gold amid m...
When tariffs threaten the economy, markets move fast. This guide explains what trade wars flaring again means for inv...